As reported by Höftberger in 2013, in a study of anti-GBABR encephalitis (15), patients with coexisting additional NMDAR antibodies showed prominent psychiatric symptoms, whereas patients with coexisting GAD65 antibodies developed refractory seizures. The gene discussed is GAD2; the disease is encephalitis.